COVID-19大流行期间可门诊治疗敏感病症住院趋势
这项横断面研究纳入密歇根一家大型商业健康维护组织的成人,比较疫情前(2019年3月至2020年2月)与大流行期(2020年3月至2021年2月)可门诊治疗敏感病症(ACSC)住院趋势。疫情前有1 240 409名成人(13 011 176人月),大流行期有1 206 361名成人(12 759 675人月)。校正年龄、性别、入院日历月和居住县后,大流行期任何ACSC住院的相对风险为0.72(95%CI 0.69-0.76;P<.001),降幅略大于非ACSC、非COVID-19住院(aRR 0.82;95%CI 0.81-0.83;P<.001);呼吸相关ACSC住院aRR 0.54(95%CI 0.50-0.58;P<.001)。ACSC住院中ICU入住比例和住院时长无变化。作者认为这些下降可能由多种患者层面和卫生系统层面因素所致,需进一步研究其原因和长期结局。
要点
- 大流行期任何ACSC住院风险较疫情前下降:aRR 0.72(95%CI 0.69-0.76;P<.001)。
- 呼吸相关ACSC住院降幅最大:aRR 0.54(95%CI 0.50-0.58;P<.001)。
- 糖尿病相关ACSC住院下降未达统计学显著:aRR 0.91(95%CI 0.83-1.00;P=.05)。
- 其他ACSC住院下降有统计学意义:aRR 0.79(95%CI 0.74-0.85;P<.001)。
- ACSC住院中ICU入住比例(aRR 0.99;95%CI 0.94-1.04;P=.64)和住院时长(调整发病率比1.02;95%CI 0.98-1.06;P=.33)无变化。
适用人群与场景
- 密歇根一家大型商业健康维护组织的成人参保者;疫情前(2019年3月至2020年2月)1 240 409名成人(13 011 176人月),大流行期(2020年3月至2021年2月)1 206 361名成人(12 759 675人月)。
- 大流行期51.3%的人月(n=6 547 231)为女性患者,年龄在24至64岁之间分布相对均匀。
研究设计与关键结果
- 横断面研究,纳入密歇根一家大型商业健康维护组织成人;暴露为COVID-19大流行(2020年3月至2021年2月),对照为疫情前(2019年3月至2020年2月)。
- 主要终点:大流行期任何ACSC住院相对风险为0.72(95%CI 0.69-0.76;P<.001),降幅略大于非ACSC、非COVID-19住院(aRR 0.82;95%CI 0.81-0.83;P<.001)。
- 呼吸相关ACSC住院aRR 0.54(95%CI 0.50-0.58;P<.001);糖尿病相关ACSC住院aRR 0.91(95%CI 0.83-1.00;P=.05),未达统计学显著;其他ACSC住院aRR 0.79(95%CI 0.74-0.85;P<.001)。
- ACSC住院中ICU入住比例无变化:aRR 0.99(95%CI 0.94-1.04;P=.64);住院时长无变化:调整发病率比1.02(95%CI 0.98-1.06;P=.33)。
- 校正因素为患者年龄、性别、入院日历月和居住县。
证据类型、等级与局限
- 证据类型:横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论:COVID-19大流行与ACSC及非ACSC住院减少相关,呼吸相关ACSC降幅尤其大;这些下降可能由多种与住院率相关的患者层面和卫生系统层面因素所致。
- 作者认为:需进一步研究这些下降的原因和长期结局,以理解大流行如何影响美国门诊和医院诊疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The association of the COVID-19 pandemic with the quality of ambulatory care is unknown. Hospitalizations for ambulatory care-sensitive conditions (ACSCs) are a well-studied measure of the quality of ambulatory care; however, they may also be associated with other patient-level and system-level factors.
OBJECTIVE: To describe trends in hospital admissions for ACSCs in the prepandemic period (March 2019 to February 2020) compared with the pandemic period (March 2020 to February 2021).
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study of adults enrolled in a commercial health maintenance organization in Michigan included 1 240 409 unique adults (13 011 176 person-months) in the prepandemic period and 1 206 361 unique adults (12 759 675 person-months) in the pandemic period.
EXPOSURE: COVID-19 pandemic (March 2020 to February 2021).
MAIN OUTCOMES AND MEASURES: Adjusted relative risk (aRR) of ACSC hospitalizations and intensive care unit stays for ACSC hospitalizations and adjusted incidence rate ratio of the length of stay of ACSC hospitalizations in the prepandemic (March 2019 to February 2020) vs pandemic (March 2020 to February 2021) periods, adjusted for patient age, sex, calendar month of admission, and county of residence.
RESULTS: The study population included 1 240 409 unique adults (13 011 176 person-months) in the prepandemic period and 1 206 361 unique adults (12 759 675 person-months) in the pandemic period, in which 51.3% of person-months (n = 6 547 231) were for female patients, with a relatively even age distribution between the ages of 24 and 64 years. The relative risk of having any ACSC hospitalization in the pandemic period compared with the prepandemic period was 0.72 (95% CI, 0.69-0.76; P < .001). This decrease in risk was slightly larger in magnitude than the overall reduction in non-ACSC, non-COVID-19 hospitalization rates (aRR, 0.82; 95% CI, 0.81-0.83; P < .001). Large reductions were found in the relative risk of respiratory-related ACSC hospitalizations (aRR, 0.54; 95% CI, 0.50-0.58; P < .001), with non-statistically significant reductions in diabetes-related ACSCs (aRR, 0.91; 95% CI, 0.83-1.00; P = .05) and a statistically significant reduction in all other ACSC hospitalizations (aRR, 0.79; 95% CI, 0.74-0.85; P < .001). Among ACSC hospitalizations, no change was found in the percentage that included an intensive care unit stay (aRR, 0.99; 95% CI, 0.94-1.04; P = .64), and no change was found in the length of stay (adjusted incidence rate ratio, 1.02; 95% CI, 0.98-1.06; P = .33).
CONCLUSIONS AND RELEVANCE: In this cross-sectional study of adults enrolled in a large commercial health maintenance organization plan, the COVID-19 pandemic was associated with reductions in both non-ACSC and ACSC hospitalizations, with particularly large reductions seen in respiratory-related ACSCs. These reductions were likely due to many patient-level and health system-level factors associated with hospitalization rates. Further research into the causes and long-term outcomes associated with these reductions in ACSC admissions is needed to understand how the pandemic has affected the delivery of ambulatory and hospital care in the US.
参考来源
- Becker NV, Karmakar M, Tipirneni R, et al. Trends in Hospitalizations for Ambulatory Care-Sensitive Conditions During the COVID-19 Pandemic. JAMA Netw Open. 2022. PMID: 35297972. doi:10.1001/jamanetworkopen.2022.2933
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。